Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

ADENINE CRS (50 MG)

ADENINE CRS (50 MG)

73-24-5

DISCOVER
ADENOSINE CRS (50 MG)

ADENOSINE CRS (50 MG)

58-61-7

DISCOVER
ADRENALINE TARTRATE CRS (100 MG)

ADRENALINE TARTRATE CRS (100 MG)

51-42-3

DISCOVER
ALANINE CRS (60 MG)

ALANINE CRS (60 MG)

56-41-7

DISCOVER
ALBENDAZOLE CRS (50 MG)

ALBENDAZOLE CRS (50 MG)

54965-21-8

DISCOVER
ALCURONIUM CHLORIDE CRS (50 MG)

ALCURONIUM CHLORIDE CRS (50 MG)

15180-03-7

DISCOVER
ALFACALCIDOL CRS (15 MG)

ALFACALCIDOL CRS (15 MG)

41294-56-8

DISCOVER
ALFACALCIDOL - REFERENCE SPECTRUM (N/A)

ALFACALCIDOL - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
Alfentanil hydrochloride - reference spectrum, Qty : n/a

Alfentanil hydrochloride - reference spectrum, Qty : n/a

NA

DISCOVER
ALFUZOSIN HYDROCHLORIDE CRS (10 MG)

ALFUZOSIN HYDROCHLORIDE CRS (10 MG)

81403-68-1

DISCOVER
ALLANTOIN CRS (60 MG)

ALLANTOIN CRS (60 MG)

97-59-6

DISCOVER
ALLOPURINOL CRS (100 MG)

ALLOPURINOL CRS (100 MG)

315-30-0

DISCOVER